Appco Pharma, LLC
FDA inspection history in Somerset, New Jersey, 2019
- 1
- Form 483
Every document, by year
- Form 483
2019: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2019One Form 483, at Somerset, New Jersey.
Cited most
Across all Appco Pharma observations on file
- 21 CFR 314.80(c)(2)Postmarketing reporting of adverse drug experiences1
The complete Appco Pharma file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Somerset, New Jersey
One Form 483 · 2019 · 1 observation
Latest: Form 483, Apr 15, 2019 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2019-04-15 | 483 Form 483 | Somerset, New Jersey | 1 | $99 |
Investigators on these documents
FEI number 3008793007 · most recent document Apr 15, 2019
About Appco Pharma, LLC
How many FDA Form 483s has Appco Pharma, LLC received?
FDA Intel has 1 Form 483 on file for Appco Pharma, LLC; the most recent is dated Apr 15, 2019.
When was Appco Pharma, LLC last inspected by FDA?
The most recent FDA inspection document on file for Appco Pharma, LLC is a Form 483 dated Apr 15, 2019, for the site in Somerset, New Jersey.
What did FDA cite at Appco Pharma, LLC?
The regulations cited most in the observations on file for Appco Pharma, LLC are 21 CFR 314.80(c)(2) (Postmarketing reporting of adverse drug experiences), 1 time.